272 |
Smart TAVR Valve Selection in Asian Patients With Different Anatomy: What We Should More Consider? |
Yohei Ohno |
Apr. 19. 24 |
271 |
TAVR in Moderate AS with Heart Failure |
Michael Kang-Yin Lee |
Apr. 19. 24 |
270 |
TAVR Explant: The NEXT Challenging Issue in Lifetime TAVR Management |
Tsuyoshi Kaneko |
Apr. 19. 24 |
269 |
TAVR-in-TAVR: The NEXT Challenging Issue in Lifetime TAVR Management |
Philippe Garot |
Apr. 19. 24 |
268 |
Essentials of Lifetime Management of Aortic Disease: Updated and Novel Points in 2024 |
Eberhard Grube |
Apr. 19. 24 |
267 |
Antiplatelets Only Not Sufficient: Still Room for NOAC |
Jean-Philippe Collet |
Apr. 12. 21 |
266 |
What Should We Care About During the MitraClip Procedure? |
Geon-Jae Lee |
Apr. 12. 21 |
265 |
TAVAR for Bicuspid Valve |
Dong Joon Lee |
Apr. 12. 21 |
264 |
Optimal Deployment Projection of TAVAR |
Seung Yong Lee |
Apr. 12. 21 |
263 |
Focus on the Patient Outcomes that Truly Matter: Clinical Perspective Update |
Rebecca Hahn |
Apr. 12. 21 |